Leerink Partners Starts Invuity (IVTY) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts IVTY Hot Sheet
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 19
Join SI Premium – FREE
Leerink Partners initiates coverage on Invuity (NASDAQ: IVTY) with a Outperform rating and a price target of $19.00.
Analyst Richard Newitter commented, "We initiate with an OP on Invuity (IVTY), an early-stage MedTech company with an advanced photonics solution to enhance visualization capabilities during surgery. Our $19 PT is based on a 5.3x '16E EV/Sales multiple (supported by DCF)--a level warranted in our view given IVTY's large market opportunity & above-avg. growth prospects."
For an analyst ratings summary and ratings history on Invuity click here. For more ratings news on Invuity click here.
Shares of Invuity closed at $14.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Assumes Evommune Inc (EVMN) at Overweight
- Bajaj Finance Ltd. (BAF:IN) PT Lowered to INR1,260 at JPMorgan
- Morgan Stanley Assumes Incyte (INCY) at Equalweight
Create E-mail Alert Related Categories
Analyst Comments, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
